Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
329 Early blood cell count test (BCT) for survival prediction for non-small cell lung cancer patients treated with atezolizumab: integrated analysis of 4 multicenter clinical trials
Compose a Response to This Article
Other responses
No responses have been published for this article.